Literature DB >> 31027746

Unique Case of Pseudoprogression Manifesting as Lung Cavitation After Pembrolizumab Treatment.

Kentaro Masuhiro1, Takayuki Shiroyama2, Izumi Nagatomo1, Atsushi Kumanogoh1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31027746     DOI： 10.1016/j.jtho.2018.12.024

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  8 in total

1.  Lung cavitation in lung metastases of gastric and non-small-cell lung cancer patients treated with apatinib.

Authors:  Fabiana Letizia Cecere; Andres Aguilar; Rafael Rosell
Journal:  Transl Lung Cancer Res       Date:  2019-08

Review 2.  How to differentiate pseudoprogression from true progression in cancer patients treated with immunotherapy.

Authors:  Yiming Ma; Qiwei Wang; Qian Dong; Lei Zhan; Jingdong Zhang
Journal:  Am J Cancer Res       Date:  2019-08-01       Impact factor: 6.166

Review 3.  Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer.

Authors:  Dristhi Ragoonanan; Sajad J Khazal; Hisham Abdel-Azim; David McCall; Branko Cuglievan; Francesco Paolo Tambaro; Ali Haider Ahmad; Courtney M Rowan; Cristina Gutierrez; Keri Schadler; Shulin Li; Matteo Di Nardo; Linda Chi; Alison M Gulbis; Basirat Shoberu; Maria E Mireles; Jennifer McArthur; Neena Kapoor; Jeffrey Miller; Julie C Fitzgerald; Priti Tewari; Demetrios Petropoulos; Jonathan B Gill; Christine N Duncan; Leslie E Lehmann; Sangeeta Hingorani; Joseph R Angelo; Rita D Swinford; Marie E Steiner; Fiorela N Hernandez Tejada; Paul L Martin; Jeffery Auletta; Sung Won Choi; Rajinder Bajwa; Natalie Dailey Garnes; Partow Kebriaei; Katayoun Rezvani; William G Wierda; Sattva S Neelapu; Elizabeth J Shpall; Selim Corbacioglu; Kris M Mahadeo
Journal:  Nat Rev Clin Oncol       Date:  2021-02-19       Impact factor: 65.011

4.  Case Report: Transformation From Cold to Hot Tumor in a Case of NSCLC Neoadjuvant Immunochemotherapy Pseudoprogression.

Authors:  Wenxiao Jia; Hui Zhu; Qianqian Gao; Jian Sun; Fujian Tan; Qun Liu; Hongbo Guo; Jinming Yu
Journal:  Front Immunol       Date:  2021-02-17       Impact factor: 7.561

5.  Immune cell gene expression signatures in diffuse glioma are associated with IDH mutation status, patient outcome and malignant cell state, and highlight the importance of specific cell subsets in glioma biology.

Authors:  Bharati Mehani; Saleembhasha Asanigari; Hye-Jung Chung; Karen Dazelle; Arashdeep Singh; Sridhar Hannenhalli; Kenneth Aldape
Journal:  Acta Neuropathol Commun       Date:  2022-02-10       Impact factor: 7.801

6.  Peritoneal Recurrence of Cecal Cancer with Specific Imaging Findings and Shrinkage after Treatment with Pembrolizumab.

Authors:  Tomohiro Takeda; Tatsuya Shonaka; Ryotaro Shimazaki; Yuki Adachi; Masahide Otani; Wakako Matsushita; Chikayoshi Tani; Kimiharu Hasegawa; Yasuo Sumi
Journal:  J Anus Rectum Colon       Date:  2022-01-28

7.  Pseudoprogression in lung cancer: a case report.

Authors:  Giulia Meoni; Nicola Libertà Decarli; Maurizio Benucci; Claudio Raspanti; Angela Stefania Ribecco
Journal:  Explor Target Antitumor Ther       Date:  2020-10-30

8.  The value of bronchial and cavity contraction rates in differentiating benign and malignant pulmonary cavities.

Authors:  Hua Zhang; Xia Qian; Zheng-Hua Liu; Yi Gong
Journal:  BMC Pulm Med       Date:  2020-08-06       Impact factor: 3.317
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.